DÉRIVÉS DE BENZIMIDAZOLE ET D'INDOLE SUBSTITUÉS PAR DE L'OXADIAZOLE ET OXAZOLE COMME INHIBITEURS DE DGAT1
- 专利权人:
- NOVARTIS AG
- 发明人:
- 申请号：
- EP08804779.0
- 公开号：
- EP2205595B1
- 申请日:
- 2008.09.26
- 申请国别(地区):
- EP
- 年份:
- 2014
- 代理人:
- 摘要：
- The present invention provides compounds of the following structure； A-Q-B&mdash；C-D that are useful for treating conditions or disorders associated with DGAT1 activity in animals, particularly humans.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS
- OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS
- Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as DGAT1 inhibitors
- - - - -OXADIAZOLE- AND OXAZOLE-SUBSTITUTED BENZIMIDAZOLE- AND INDOLE-DERIVATIVES AS DGAT1 INHIBITORS
- Oxadiazole and oxazole-substituted benzimidazole and indole derivatives as dgat1 inhibitors
